Clinical Trial Update: Surgical or Radiotherapeutic Intervention Concerning Large Singular Stable to Progressive Metastases in Patients With BRAFV600-mutated Melanoma Receiving Treatment With Encorafenib + Binimetinib [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating surgical or radiotherapeutic intervention for large singular metastases in BRAFV600-mutated melanoma patients treated with e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Binimetinib (binimetinib)
• Encorafenib (encorafenib)

Snippet

Sponsor: SRH Wald-Klinikum Gera GmbH | Conditions: Melanoma BRAF V600E/K Mutated | Phase 4 | Status: WITHDRAWN